241 related articles for article (PubMed ID: 16641093)
1. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.
Tuncman G; Erbay E; Hom X; De Vivo I; Campos H; Rimm EB; Hotamisligil GS
Proc Natl Acad Sci U S A; 2006 May; 103(18):6970-5. PubMed ID: 16641093
[TBL] [Abstract][Full Text] [Related]
2. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians.
Vimaleswaran KS; Radha V; Mohan V
Metabolism; 2006 Sep; 55(9):1222-6. PubMed ID: 16919542
[TBL] [Abstract][Full Text] [Related]
3. Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability.
Saksi J; Ijäs P; Mäyränpää MI; Nuotio K; Isoviita PM; Tuimala J; Lehtonen-Smeds E; Kaste M; Jula A; Sinisalo J; Nieminen MS; Lokki ML; Perola M; Havulinna AS; Salomaa V; Kettunen J; Jauhiainen M; Kovanen PT; Lindsberg PJ
Circ Cardiovasc Genet; 2014 Oct; 7(5):588-98. PubMed ID: 25122052
[TBL] [Abstract][Full Text] [Related]
4. Human tyrosine hydroxylase natural genetic variation: delineation of functional transcriptional control motifs disrupted in the proximal promoter.
Zhang K; Zhang L; Rao F; Brar B; Rodriguez-Flores JL; Taupenot L; O'Connor DT
Circ Cardiovasc Genet; 2010 Apr; 3(2):187-98. PubMed ID: 20124442
[TBL] [Abstract][Full Text] [Related]
5. Role of the fatty acid binding protein mal1 in obesity and insulin resistance.
Maeda K; Uysal KT; Makowski L; Görgün CZ; Atsumi G; Parker RA; Brüning J; Hertzel AV; Bernlohr DA; Hotamisligil GS
Diabetes; 2003 Feb; 52(2):300-7. PubMed ID: 12540600
[TBL] [Abstract][Full Text] [Related]
6. Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity.
Ertunc ME; Sikkeland J; Fenaroli F; Griffiths G; Daniels MP; Cao H; Saatcioglu F; Hotamisligil GS
J Lipid Res; 2015 Feb; 56(2):423-34. PubMed ID: 25535287
[TBL] [Abstract][Full Text] [Related]
7. Generation of porcine fibroblasts overexpressing 11β-HSD1 with adipose tissue-specific aP2 promoter as a porcine model of metabolic syndrome.
Jung EM; An BS; Kim YK; Jeong YH; Hwang WS; Jeung EB
Mol Med Rep; 2013 Sep; 8(3):751-6. PubMed ID: 23864280
[TBL] [Abstract][Full Text] [Related]
8. AP2-NR4A3 transgenic mice display reduced serum epinephrine because of increased catecholamine catabolism in adipose tissue.
Walton RG; Zhu X; Tian L; Heywood EB; Liu J; Hill HS; Liu J; Bruemmer D; Yang Q; Fu Y; Garvey WT
Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E69-81. PubMed ID: 27166283
[TBL] [Abstract][Full Text] [Related]
9. Improved glucose and lipid metabolism in genetically obese mice lacking aP2.
Uysal KT; Scheja L; Wiesbrock SM; Bonner-Weir S; Hotamisligil GS
Endocrinology; 2000 Sep; 141(9):3388-96. PubMed ID: 10965911
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the Thr79Met polymorphism of the ileal fatty acid binding protein (FABP6) to be associated with type 2 diabetes in obese individuals.
Fisher E; Grallert H; Klapper M; Pfäfflin A; Schrezenmeir J; Illig T; Boeing H; Döring F
Mol Genet Metab; 2009 Dec; 98(4):400-5. PubMed ID: 19744871
[TBL] [Abstract][Full Text] [Related]
11. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
Krempler F; Esterbauer H; Weitgasser R; Ebenbichler C; Patsch JR; Miller K; Xie M; Linnemayr V; Oberkofler H; Patsch W
Diabetes; 2002 Nov; 51(11):3331-5. PubMed ID: 12401727
[TBL] [Abstract][Full Text] [Related]
12. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
Furuhashi M; Tuncman G; Görgün CZ; Makowski L; Atsumi G; Vaillancourt E; Kono K; Babaev VR; Fazio S; Linton MF; Sulsky R; Robl JA; Parker RA; Hotamisligil GS
Nature; 2007 Jun; 447(7147):959-65. PubMed ID: 17554340
[TBL] [Abstract][Full Text] [Related]
13. Anti-obesity effects of germinated brown rice extract through down-regulation of lipogenic genes in high fat diet-induced obese mice.
Ho JN; Son ME; Lim WC; Lim ST; Cho HY
Biosci Biotechnol Biochem; 2012; 76(6):1068-74. PubMed ID: 22790925
[TBL] [Abstract][Full Text] [Related]
14. Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice.
Cao H; Maeda K; Gorgun CZ; Kim HJ; Park SY; Shulman GI; Kim JK; Hotamisligil GS
Diabetes; 2006 Jul; 55(7):1915-22. PubMed ID: 16804058
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.
Kamei N; Tobe K; Suzuki R; Ohsugi M; Watanabe T; Kubota N; Ohtsuka-Kowatari N; Kumagai K; Sakamoto K; Kobayashi M; Yamauchi T; Ueki K; Oishi Y; Nishimura S; Manabe I; Hashimoto H; Ohnishi Y; Ogata H; Tokuyama K; Tsunoda M; Ide T; Murakami K; Nagai R; Kadowaki T
J Biol Chem; 2006 Sep; 281(36):26602-14. PubMed ID: 16809344
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.
Xu H; Hertzel AV; Steen KA; Wang Q; Suttles J; Bernlohr DA
Mol Cell Biol; 2015 Mar; 35(6):1055-65. PubMed ID: 25582199
[TBL] [Abstract][Full Text] [Related]
17. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.
Boord JB; Maeda K; Makowski L; Babaev VR; Fazio S; Linton MF; Hotamisligil GS
Circulation; 2004 Sep; 110(11):1492-8. PubMed ID: 15353487
[TBL] [Abstract][Full Text] [Related]
18. Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.
Gormez S; Erdim R; Akan G; Caynak B; Duran C; Gunay D; Sozer V; Atalar F
Cardiovasc Pathol; 2020; 46():107192. PubMed ID: 31927390
[TBL] [Abstract][Full Text] [Related]
19. Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation.
Melki SA; Abumrad NA
J Lipid Res; 1993 Sep; 34(9):1527-34. PubMed ID: 7693843
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone action is independent of adipose tissue.
Burant CF; Sreenan S; Hirano K; Tai TA; Lohmiller J; Lukens J; Davidson NO; Ross S; Graves RA
J Clin Invest; 1997 Dec; 100(11):2900-8. PubMed ID: 9389757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
